theory clinical_1_5
imports Main

begin

typedecl entity
typedecl event

consts
  Olaparib :: "entity ⇒ bool"
  Rucaparib :: "entity ⇒ bool"
  PARP1Inhibitor :: "entity ⇒ bool"
  LicensedForUseIn :: "entity ⇒ entity ⇒ bool"
  ProstateCancerPatient :: "entity ⇒ bool"
  TreatmentOption :: "entity ⇒ bool"
  Patient :: "entity ⇒ bool"
  LossOfBRCA2 :: "entity ⇒ bool"
  MechanismOfAction :: "entity ⇒ bool"
  PARP1Inhibition :: "entity ⇒ bool"
  SyntheticLethality :: "entity ⇒ bool"
  Benefit :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Source :: "event ⇒ entity ⇒ bool"
  Reason :: "event ⇒ entity ⇒ bool"
  Cause :: "event ⇒ bool"
  Rely :: "event ⇒ bool"
  Mechanism :: "event ⇒ bool"
  Repair :: "event ⇒ bool"
  DamageToDNA :: "event ⇒ bool"
  Has :: "event ⇒ bool"
  Make :: "event ⇒ bool"
  For :: "entity ⇒ entity ⇒ bool"

(* Explanation 1: Olaparib is a PARP1 inhibitor licensed for use in prostate cancer patients and is a potential treatment option for any patient with loss of BRCA2 due to its mechanism of action. *)
axiomatization where
  explanation_1: "∀x y z. Olaparib x ∧ PARP1Inhibitor x ∧ LicensedForUseIn x y ∧ ProstateCancerPatient y ∧ TreatmentOption x ∧ Patient z ∧ LossOfBRCA2 z ∧ MechanismOfAction x"

(* Explanation 2: Rucaparib is a PARP1 inhibitor licensed for use in prostate cancer patients and is a potential treatment option for any patient with loss of BRCA2 due to its mechanism of action. *)
axiomatization where
  explanation_2: "∀x y z. Rucaparib x ∧ PARP1Inhibitor x ∧ LicensedForUseIn x y ∧ ProstateCancerPatient y ∧ TreatmentOption x ∧ Patient z ∧ LossOfBRCA2 z ∧ MechanismOfAction x"

(* Explanation 3: Patients with loss of BRCA2 may benefit from PARP1 inhibition due to synthetic lethality, which causes cells to rely on a singular mechanism to repair cumulative damage to DNA, making Olaparib and Rucaparib viable treatment options. *)
axiomatization where
  explanation_3: "∀x y z e1 e2 e3. Patient x ∧ LossOfBRCA2 x ∧ PARP1Inhibition y ∧ SyntheticLethality z ∧ Benefit e1 ∧ Agent e1 x ∧ Source e1 y ∧ Reason e1 z ∧ Cause e2 ∧ Agent e2 z ∧ Source e2 y ∧ Rely e3 ∧ Agent e3 y ∧ Mechanism e3 ∧ Repair e3 ∧ DamageToDNA e3 ∧ Olaparib a ∧ Rucaparib b ∧ TreatmentOption a ∧ TreatmentOption b"

(* Explanation 4: The patient in question has a loss of BRCA2, which makes both Olaparib and Rucaparib viable treatment options for them. *)
axiomatization where
  explanation_4: "∃x y z e1 e2. Patient x ∧ LossOfBRCA2 y ∧ Has e1 ∧ Agent e1 x ∧ Source e1 y ∧ Make e2 ∧ Agent e2 y ∧ Olaparib z ∧ Rucaparib w ∧ TreatmentOption z ∧ TreatmentOption w ∧ For z x ∧ For w x"

theorem hypothesis:
  assumes asm: "Patient y"
  (* Hypothesis: There are two potential treatment options for this patient *)
  shows "∃x y. TreatmentOption x ∧ Patient y ∧ For x y"
proof -
  (* From the premise, we have the known information about the patient. *)
  from asm have "Patient y" by simp
  (* Explanation 4 states that the patient has a loss of BRCA2, making both Olaparib and Rucaparib viable treatment options. *)
  (* This directly implies that there are two treatment options for the patient. *)
  from explanation_4 have "∃x z w. Patient y ∧ LossOfBRCA2 y ∧ Olaparib z ∧ Rucaparib w ∧ TreatmentOption z ∧ TreatmentOption w ∧ For z y ∧ For w y" sledgehammer
  (* We can extract the existence of treatment options for the patient from this explanation. *)
  then have "∃x. TreatmentOption x ∧ Patient y ∧ For x y" <ATP>
  then show ?thesis <ATP>
qed

end
